Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Evotec
Deal Size : Undisclosed
Deal Type : Partnership
Peptone Partners with Evotec to Target IDPs and Scale Small-Molecule Therapies
Details : Through the partnership, Peptone will harness Evotec's drug discovery toolbox, encompassing deep domain expertise in oncology and immunology.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
May 08, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Evotec
Deal Size : Undisclosed
Deal Type : Partnership
Details : The collaboration will focus on the identification and progression of novel targets in oncology using translational models to develop innovative medicines for patients suffering from prostate cancer.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
November 30, 2023